Reported Safety Considerations in the Research Literature Safety data on IGF-1 LR3 in the research literature center on its glucose-lowering and cell-proliferation effects, both direct consequences of the same receptor signaling responsible for its studied anabolic and metabolic outcomes
Pregnant and breastfeeding women need up to 2.8 mcg
For long-term metabolic resilience, the goal may not simply be to mimic these signals with drugs, but to restore the dietary environment that allows the body to produce them naturally
Accessed at utswmed.org/medblog/obesitymedication-weight-program
Third, immortal time bias may artificially inflate apparent protective effects if the period between cohort entry and treatment initiation is misclassified as exposed time
SCFAs inhibit the growth of Enterobacteriaceae [148], which produce LPS, thus indirectly suppressing inflammatory processes